Abstract
Background: Hepatopulmonary syndrome (HPS) is a pulmonary complication of liver disease found in 10% to 32% of patients with cirrhosis. It is characterized by intrapulmonary vascular dilatations and abnormal oxygenation. Liver transplantation is currently the only effective therapy. Patients with HPS face significant exercise limitations, which impact their quality of life and are associated with poor liver transplant outcomes. Many HPS patients exhibit orthodeoxia—an improvement in oxygenation in the supine compared to the upright position. We hypothesize that exercise capacity will be superior in the supine position for such patients.
Methods: We propose a randomized controlled crossover trial in patients with HPS and orthodeoxia. Participants will be randomized to cycle ergometry in either the supine or upright position, followed by a crossover to the alternate position. Exercise will be performed at a constant work rate (70-85% of predicted peak) until a "stopping time" is reached. The primary outcome is the difference in stopping time between positions.
Discussion: If positive, a supine exercise regimen could become a routine prescription for patients with HPS and orthodeoxia, enabling more effective pre-transplant rehabilitation.
Introduction
Hepatopulmonary Syndrome (HPS) represents a complex "cross-talk" between the liver and the lungs. In a significant portion of patients with cirrhosis, the liver fails to clear certain vasodilators, leading to excessive dilation of small pulmonary blood vessels. This results in a "diffusion-perfusion defect" where blood flows too rapidly through vessels that are too wide for efficient oxygen exchange.
A defining characteristic of HPS is orthodeoxia—a significant drop in blood oxygen levels when moving from a lying (supine) to an upright position. Gravity pulls more blood toward the dilated vessels at the base of the lungs when upright, causing oxygen saturation to plummet. This physiological quirk makes standard exercise nearly impossible, leading to severe deconditioning in patients awaiting life-saving liver transplants.
The Challenge of Exercise in HPS
Exercise capacity is a critical predictor of survival following liver transplantation. However, as shown in the summary of existing literature below, patients with HPS consistently demonstrate reduced peak oxygen uptake (VO2peak), progressive hypoxemia, and diminished workloads compared to other patients with cirrhosis.
Study Design and Methods
The proposed study is a randomized controlled crossover trial designed to test whether neutralizing gravity can improve exercise duration. By using each participant as their own control, the study can accurately measure the impact of body position on performance.
The Protocol
- Participants: 10 patients with moderate HPS and confirmed orthodeoxia.
- Intervention: Participants perform a Constant Work Rate Exercise Test (CWRET) at 70–85% of their predicted peak capacity in two positions: Upright (90° cycle ergometry) and Supine (0° cycle ergometry on a specialized Stress EchoBed).
- Primary Metric: The study measures "stopping time" (tLIM)—the duration a patient can maintain exercise before reaching exhaustion or safety limits (such as profound desaturation or blood pressure drops).
Preliminary Data and Power Analysis
To inform the trial design, researchers analyzed the Canadian HPS Program Database (n=56). This preliminary analysis revealed that 66.1% of HPS patients exhibit orthodeoxia, with lower baseline oxygen levels and lower lung diffusion capacity (DLCO) serving as key predictors. Based on these data, the team determined that a sample of 10 participants provides sufficient statistical power to detect a clinically meaningful improvement of 2.85 minutes in exercise time.
Discussion and Expected Impact
The core innovation of this trial is the use of gravity as a therapeutic tool. While most previous studies used incremental tests that caused patients to stop due to rapid desaturation, this protocol uses a constant-rate test in a supine position. This approach may finally allow HPS patients to achieve a true cardiovascular workout without the immediate limiting factor of orthodeoxia.
If the hypothesis holds, supine exercise could become a standard "pre-habilitation" prescription. Future research will need to explore whether long-term supine training translates into improved quality of life and better post-operative survival for liver transplant candidates.
Trial Registration: The ClinicalTrials.gov Protocol Registration and Results System (PRS): NCT04004104. Registered on 1st July 2019.
Summary updated